Mizuho set a $38.00 price objective on shares of Envision Healthcare and gave the company a "hold" rating in a research note on Friday, March 2nd. The company's management has engaged with a wide range of advisers and has invited offers for all or part of the business from potential suitors. Finally, Zeke Capital Advisors LLC bought a new position in shares of Envision Healthcare during the 1st quarter worth about $229,000. JPMorgan Chase & Co. increased its stake in Envision Healthcare by 2,034.5% in the first quarter. Aperio Group LLC now owns 71,295 shares of the company's stock worth $2,464,000 after acquiring an additional 45,668 shares during the period. Institutional investors own 35.96% of the company's stock. This represents a 32% premium to the company's volume-weighted average share price from November 1 2017.
KKR & Co (KKR.N) said on Monday it will buy Envision Healthcare Corp (EVHC.N), one of biggest US providers of physicians to hospitals, in a deal valued at $5.57 billion as it builds up its healthcare portfolio. They expect $0.80 earnings per share, up 1.27 % or $0.01 from last year's $0.79 per share. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The business had revenue of $2.08 billion for the quarter, compared to analyst estimates of $2.02 billion. During the same quarter last year, the firm posted $0.77 EPS. analysts anticipate that Envision Healthcare will post 3.39 earnings per share for the current year.
A number of research firms have issued reports on EVHC.
Among 13 analysts covering Envision Healthcare (NYSE:EVHC), 8 have Buy rating, 0 Sell and 5 Hold. The stock of Envision Healthcare Corporation (NYSE:EVHC) has "Hold" rating given on Wednesday, February 28 by Piper Jaffray. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned "Hold" rating by Cantor Fitzgerald on Monday, May 7. As per Wednesday, April 11, the company rating was maintained by Robert W. Baird. Cantor Fitzgerald maintained the stock with "Hold" rating in Tuesday, April 10 report. Cantor Fitzgerald maintained the stock with "Hold" rating in Wednesday, February 21 report. The company presently has an average rating of "Buy" and a consensus price target of $68.33. The stock of Envision Healthcare Corporation (NYSE:EVHC) has "Outperform" rating given on Wednesday, January 31 by Credit Suisse. The sale was disclosed in a filing with the SEC, which is accessible through this link. The investigation concerns whether the Board of Envision Healthcare breached their fiduciary duties to shareholders and whether KKR is underpaying for the Company.
The company has been hit by lower patient admissions at hospitals - a trend that has plagued healthcare services providers in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR).